Raymond James Starts Sage Therapeutics (SAGE) at Outperform

September 13, 2016 6:53 AM EDT
Get Alerts SAGE Hot Sheet
Price: $50.10 -2.87%

Rating Summary:
    12 Buy, 0 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade SAGE Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Raymond James initiated coverage on Sage Therapeutics (NASDAQ: SAGE) with an Outperform rating and a price target of $75.00.

For an analyst ratings summary and ratings history on Sage Therapeutics click here. For more ratings news on Sage Therapeutics click here.

Shares of Sage Therapeutics closed at $40.61 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Hot New Coverage, New Coverage

Related Entities

Raymond James

Add Your Comment